Another Positive Study, page-175

2884 ‘PEMthrox’ – A quality improvement project introducing inhaled methoxyflurane for procedural analgesia in a tertiary paediatric emergency department
https://doi.org/10.1136/emermed-2024-RCEM.9

Results and Conclusion 62 patients received Penthrox during the audit period, data collection was complete for 48 patients.

There were 6 esketamine sedations during the audit period compared with 29 in the same period in 2023.

Procedures, mostly fracture manipulations, were well tolerated under Penthrox (83%, 40/48)

Penthrox is easy to use in this patient population, with adequate technique by most patients (98%, 47/48)

Introduction of Penthrox has significantly reduced esketamine sedations within the Emergency Department. It is well tolerated and safe to use in the paediatric emergency department.